Erin H Seeley

Title: Erin H. Seeley: Innovator in Melanoma Differentiation

Introduction

Erin H. Seeley is a prominent inventor based in Nashville, TN (US). She has made significant contributions to the field of dermatopathology through her innovative research and patented methodologies. Her work focuses on improving the accuracy of melanoma diagnosis, which is crucial for effective treatment.

Latest Patents

Erin H. Seeley holds a patent for a groundbreaking invention titled "Method for differentiating Spitz nevi from spitzoid malignant melanoma." This invention utilizes a mass spectrometry proteomic approach to distinguish between Spitz nevi and Spitzoid malignant melanoma. The method employs histology-directed mass spectral profiling, allowing for targeted analysis of melanocytic lesions within formalin-fixed, paraffin-embedded excisional biopsies. The classification system identified five peptide peaks, with two originating from vimentin and actin. Remarkably, the invention achieved a sensitivity of 97% and a specificity of 90% for Spitz nevi.

Career Highlights

Erin H. Seeley is affiliated with Vanderbilt University, where she continues her research and development in the field of proteomics and dermatopathology. Her work has garnered attention for its potential to enhance diagnostic accuracy and patient outcomes in melanoma cases.

Collaborations

One of her notable collaborators is Richard Caprioli, who has worked alongside her in advancing the methodologies related to her patent. Their combined expertise has contributed to the success of their research initiatives.

Conclusion

Erin H. Seeley's innovative approach to differentiating melanoma types represents a significant advancement in medical diagnostics. Her contributions are vital for improving patient care and outcomes in dermatology.